Երկիր: Իռլանդիա
Լեզու: անգլերեն
Աղբյուրը: HPRA (Health Products Regulatory Authority)
DEXTRAN 40 GLUCOSE
Baxter Healthcare Limited
DEXTRAN 40 GLUCOSE
10/5 %w/v %w/v
Solution for Infusion
Withdrawn
2007-10-04
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dextran 40 Intravenous Infusion BP 10% w/v in Glucose Intravenous Infusion BP 5.0% w/v. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1000 ml contains: For excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Infusion. A clear, colourless, sterile, aqueous solution for infusion. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dextran 40 is used for early fluid replacement or for plasma volume expansion in the adjunctive treatment of certain types of shock, or in impending shock when whole blood or fluid products are not available, including shock resulting from burns, surgery, haemorrhage or trauma, in which circulating volume deficit is present. It should not replace other forms of therapy known to be of value in the treatment of shock. It may be used to improve blood flow and tissue function in conditions associated with local ischaemia e.g. peripheral limb ischaemia. It is also used as a priming fluid either as a sole agent or as an additive in pump oxygenators during extra-corporal circulation. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION DOSAGE The recommended dosage is dependant upon the age, weight and clinical condition of the patient. _Hypovolaemic shock_ The usual dose is 500 to 1000ml, depending on individual response. This dose should not be exceeded except in unusual circumstances. Recommended dosage to children is 10ml/kg and to babies 5ml/kg. _To improve blood flow and tissue function in burns and conditions associated with local ischaemia_ The usual dose is 500ml prior to surgery and 500ml during surgery. Dosage depends on individual patient circumstances and response. Dextran 40 /Dextran 40 for Injection 100 g Anhydrous glucose 50 g or glucose Monohydrate 55 g IRISH MEDICIN Կարդացեք ամբողջական փաստաթուղթը